Schizophrenia Research
Volume 75, Issue 1 , Pages 45-54 , 1 June 2005

A 3-year prospective study of neurological soft signs in first-episode schizophrenia

  • Eric Yu-Hai Chen

      Affiliations

    • Department of Psychiatry, University of Hong Kong. Queen Mary Hospital, Pokfulam Road, Hong Kong
    • Corresponding Author InformationCorresponding author. Tel.: +852 28554488; fax: +852 28551345.
    • ,
  • Christy Lai-Ming Hui

      Affiliations

    • Department of Psychiatry, University of Hong Kong. Queen Mary Hospital, Pokfulam Road, Hong Kong
    • ,
  • Raymond Chor-Kiu Chan

      Affiliations

    • Department of Psychiatry, University of Hong Kong. Queen Mary Hospital, Pokfulam Road, Hong Kong
    • Department of Psychology, Sun Yat-Sen University, Guangzhou, China
    • ,
  • Eva Lai-Wah Dunn

      Affiliations

    • Department of Psychiatry, Pamela Youde Nethersole Eastern Hospital, Hong Kong
    • ,
  • May Yin-King Miao

      Affiliations

    • Department of Psychiatry, Pamela Youde Nethersole Eastern Hospital, Hong Kong
    • ,
  • Wai-Song Yeung

      Affiliations

    • Department of Psychiatry, Pamela Youde Nethersole Eastern Hospital, Hong Kong
    • ,
  • Chi-Keung Wong

      Affiliations

    • Department of Psychiatry, Pamela Youde Nethersole Eastern Hospital, Hong Kong
    • ,
  • Wah-Fat Chan

      Affiliations

    • Department of Psychiatry, Pamela Youde Nethersole Eastern Hospital, Hong Kong
    • ,
  • Wai-Nang Tang

      Affiliations

    • Department of Psychiatry, Pamela Youde Nethersole Eastern Hospital, Hong Kong

Received 12 August 2004 ,Revised 23 August 2004 ,Accepted 6 September 2004.

References 

  1. Addington J, Addington D. Positive and negative symptoms of schizophrenia. Their course and relationship over time. Schizophrenia Research. 1991;5:51–59
  2. American Psychiatric Association . DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. 4th edition. Washington, DC: American Psychiatric Association; 1994;
  3. Andreasen NC, Flaum M, Arndt S. The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Archives of General Psychiatry. 1992 Aug.;49(8):615–623UI:1637251
  4. Arango C, Bartko JJ, Gold JM, Buchanan RW. Prediction of neuropsychological performance by neurological signs in schizophrenia. American Journal of Psychiatry. 1999;156:1349–1357
  5. Barnes TR. A rating scale for drug induced akathisia. British Journal of Psychiatry. 1989;154:672–676
  6. Boks MP, Russo S, Knegtering R, van den Bosch RJ. The specificity of neurological signs in schizophrenia: a review. Schizophrenia Research. 2000;43:109–116
  7. Browne S, Clarke M, Gervin M, Lane A, Waddington JL, Larkin C, et al. Determinants of neurological dysfunction in first episode schizophrenia. Psychological Medicine. 2000;30:1433–1441
  8. Buchanan RW, Heinrichs DW. The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Research. 1989;27:335–350
  9. Cannon S, Potkin SG, Wyatt RJ. Measurement of premorbid adjustment in chronic schizophrenia. Schizophrenia Bulletin. 1982;8:470–484
  10. Carr V, Halpin S, Lau N, O'Brien S, Beckmann J, Lewin T. A risk factor screening and assessment protocol for schizophrenia and related psychosis. Australian & New Zealand Journal of Psychiatry. 2000 Nov.;34(Suppl):S170–S180
  11. Chen EYH, Chan RCK. The Cambridge neurological inventory: clinical, demographic and ethnic correlates. Psychiatric Annals. 2003;33:202–210
  12. Chen EY, Shapleske J, Luque R, McKenna PJ, Hodges JR, Calloway SP, et al. The Cambridge neurological inventory: a clinical instrument for assessment of soft neurological signs in psychiatric patients. Psychiatry Research. 1995;56:183–204
  13. Chen EY, Lam LC, Chen RY, Nguyen DG. Negative symptoms, neurological signs and neuropsychological impairments in 204 Hong Kong Chinese patients with schizophrenia. British Journal of Psychiatry. 1996;168:227–233
  14. Chen EY, Lam LC, Chen RY, Nguyen DG. Neurological signs, age, and illness duration in schizophrenia. Journal of Nervous and Mental Disease. 1996;184:339–345
  15. Chen EY, Lam LC, Chen RY, Nguyen DG, Chan CK, Wilkins AJ. Neuropsychological correlates of sustained attention in schizophrenia. Schizophrenia Research. 1997;27:299–310
  16. Chen YL, Chen YH, Mak FL. Soft neurological signs in schizophrenic patients and their nonpsychotic siblings. Journal of Nervous and Mental Disease. 2000;188:84–89
  17. Cuesta MJ, Peralta V, de Leon J. Neurological frontal signs and neuropsychological deficits in schizophrenic patients. Schizophrenia Research. 1996;20:15–20
  18. Dazzan P, Murray RM. Neurological soft signs in first-episode psychosis: a systematic review. British Journal of Psychiatry. 2002;43:s50–s57
  19. Fish B. Neurobiologic antecedents of schizophrenia in children. Archives of General Psychiatry. 1977;34:1297–1313
  20. Flyckt L, Sydow O, Bjerkenstedt L, Edman G, Rydin E, Wiesel FA. Neurological signs and psychomotor performance in patients with schizophrenia, their relatives and healthy controls. Psychiatry Research. 1999;86:113–129
  21. Foerster A, Lewis S, Owen M, Murray R. Pre-morbid adjustment and personality in psychosis. Effects of sex and diagnosis. British Journal of Psychiatry. 1991;158:171–176
  22. Gupta S, Andreasen NC, Arndt S, Flaum M, Schultz SK, Hubbard WC, et al. Neurological soft signs in neuroleptic-naive and neuroleptic-treated schizophrenic patients and in normal comparison subjects. American Journal of Psychiatry. 1995;152:191–196
  23. Guy W. ECDEU Assessment Manual for Psychopharmacology, Revised. Bethesda, MD: US Department of Health, Education and Welfare; 1976;
  24. Hafner H, Riecher-Rossler A, Hambrecht M, Maurer K, Meissner S, Schmidtke A, et al. IRAOS: an instrument for the assessment of onset and early course of schizophrenia. Schizophrenia Research. 1992;6:209–223
  25. Heinrichs DW, Buchanan RW. Significance and meaning of neurological signs in schizophrenia. American Journal of Psychiatry. 1988;145:11–18
  26. Kay SR, Fiszbein A, Opler LA. Positive and Negative Symptom Scale (PANSS) for schizophrenia. Schizophrenia Bulletin. 1988;13:21–76
  27. Keshavan MS, Sanders RD, Sweeney JA, Diwadkar VA, Goldstein G, Pettegrew JW, et al. Diagnostic specificity and neuroanatomical validity of nuerological abnormalities in first-episode psychoses. American Journal of Psychiatry. 2003 Jul.;160(7):1298–1304
  28. Kinney DK, Woods BT, Yurgelun-Todd D. Neurologic abnormalities in schizophrenic patients and their families: II. Neurologic and psychiatric findings in relatives. Archives of General Psychiatry. 1986;43:665–668
  29. Kolakowska T, Williams AO, Jambor K, Ardern M. Schizophrenia with good and poor outcome: III. Neurological ‘soft’ signs, cognitive impairment and their clinical significance. British Journal of Psychiatry. 1985;146:348–357
  30. Lawrie SM, Byrne M, Miller P, Hodges A, Clafferty RA, Cunningham-Owens DG, et al. Neurodevelopmental indices and the development of psychotic symptoms in subjects at high risk of schizophrenia. British Journal of Psychiatry. 2001;178:524–530
  31. Madsen AL, Vorstrup S, Rubin P, Larsen JK, Hemmingsen R. Neurological abnormalities in schizophrenic patients: a prospective follow-up study 5 years after first admission. Acta Psychiatrica Scandinavica. 1999;100:119–125
  32. Malla AK, Norman RM, Aguilar O, Cortese L. Relationship between neurological ‘soft signs’ and syndromes of schizophrenia. Acta Psychiatrica Scandinavica. 1997;96:274–280
  33. Marcus J, Hans SL, Mednick SA. Neurological dysfunctioning in offspring of schizophrenics in Israel and Denmark. Archives of General Psychiatry. 1985;42:753–761
  34. Merriam AE, Kay SR, Opler LA, Kushner SF, van Praag HM. Neurological signs and the positive–negative dimension in schizophrenia. Biological Psychiatry. 1990;28:181–192
  35. Mikkelsen EJ, Brown GL, Minichiello MD, Millican FK, Rapoport JL. Neurologic status in hyperactive, enuretic, encopretic, and normal boys. Journal of the American Academy of Child Psychiatry. 1982;21:75–81
  36. Mohr F, Hubmann W, Cohen R, Bender W, Haslacher C, Honicke S, et al. Neurological soft signs in schizophrenia: assessment and correlates. European Archives of Psychiatry and Clinical Neuroscience. 1996;246:240–248
  37. Mortimer AM, Lund CE, McKenna PJ. Rating of negative symptoms using the High Royds Evaluation of Negativity (HEN) Scale. British Journal of Psychiatry. 1989;155:89–91
  38. Quitkin F, Rifkin A, Klein DF. Neurologic soft signs in schizophrenia and character disorders. Archives of General Psychiatry. 1976;33:845–853
  39. Rossi A, De Cataldo S, Di Michele V, Manna V, Ceccoli S, Stratta P, et al. Neurological soft signs in schizophrenia. British Journal of Psychiatry. 1990;157:735–739
  40. Sanders RD, Keshavan MS, Schooler NR. Neurological examination abnormalities in neuroleptic-naive patients with first-break schizophrenia: preliminary results. American Journal of Psychiatry. 1994;151:1231–1233
  41. Schroder J, Geider FJ, Binkert M, Reitz C, Jauss M, Sauer H. Subsyndromes in chronic schizophrenia: do their psychopathological characteristics correspond to cerebral alterations?. Psychiatry Research. 1992;42:209–220
  42. Schroder J, Niethammer R, Geider FJ, Reitz C, Binkert M, Jauss M, et al. Neurological soft signs in schizophrenia. Schizophrenia Research. 1992;6:25–30
  43. Schroder J, Wenz F, Schad LR, Baudendistel K, Knopp MV. Sensorimotor cortex and supplementary motor area changes in schizophrenia. A study with functional magnetic resonance imaging. British Journal of Psychiatry. 1995;167:197–201
  44. Schroder J, Silvestri S, Bubeck B, Karr M, Demisch S, Scherrer S, et al. D2 dopamine receptor up-regulation, treatment response, neurological soft signs, and extrapyramidal side effects in schizophrenia: a follow-up study with 123I-iodobenzamide single photon emission computed tomography in the drug-naive state and after neuroleptic treatment. Biological Psychiatry. 1998;43:660–665
  45. Simpson GM, Angus JWS. A rating scale for extrapyramidal sign effects. Acta Psychiatrica Scandinavica. 1970;212:S11–S19
  46. Tsuang MT, Faraone SV. The concept of target features in schizophrenia research. Acta Psychiatrica Scandinavica. 1999;395:2–11
  47. Whitty P, Clarke M, Browne S, McTigue O, Kamali M, Feeney L, et al. Prospective evaluation of neurological soft signs in first-episode schizophrenia in relation to psychopathology: state versus trait phenomena. Psychological Medicine. 2003;33:1479–1484
  48. Wong AH, Voruganti LN, Heslegrave RJ, Awad AG. Neurocognitive deficits and neurological signs in schizophrenia. Schizophrenia Research. 1997;23:139–146
  49. Woods BT, Kinney DK, Yurgelun-Todd D. Neurologic abnormalities in schizophrenic patients and their families. Archives of General Psychiatry. 1986;43:657–663

PII: S0920-9964(04)00337-8

doi: 10.1016/j.schres.2004.09.002

Schizophrenia Research
Volume 75, Issue 1 , Pages 45-54 , 1 June 2005

Article Tools